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Objective: The aim of this randomized study was to compare a new method of endovenous saphenous vein obliteration
(Closure System, VNUS Medical Technologies, Inc, Sunnyvale, Calif) with the conventional stripping operation in terms
of short-term recovery and costs.
Methods: Twenty-eight selected patients for operative treatment of primary greater saphenous vein tributary varicose veins
were randomly assigned to endovenous obliteration (n  15) or stripping operation (n  13). Postoperative pain was
daily assessed during the 1st week and on the 14th postoperative day. The length of sick leave was determined. The
RAND-36 health survey was used to assess the patient health-related quality of life. The patient conditions were
controlled 7 to 8 weeks after surgery, and patients underwent examination with duplex ultrasonography. The comparison
of costs included both direct medical costs and costs resulting from lost of productivity of the patients. Costs that were
similar in the study groups were not considered in the analysis.
Results: All operations were successful, and the complication rates were similar in the two groups. Postoperative average
pain was significantly less severe in the endovenous obliteration group as compared with the stripping group (at rest: 0.7,
standard deviation [SD] 0.5, versus 1.7, SD 1.3, P  .017; on standing: 1.3, SD 0.7, versus 2.6, SD 1.9, P  .026; on
walking: 1.8, SD 0.8, versus 3.0, SD 1.8, P  .036; with t test). The sick leaves were significantly shorter in the
endovenous obliteration group (6.5 days, SD 3.3 days, versus 15.6 days, SD 6.0 days; 95% CI, 5.4 to 12.9; P < .001, with
t test). Physical function was also restored faster in the endovenous obliteration group. The estimated annual investment
costs of the closure operation were US $3360. The other direct medical costs of the Closure operation were about $850,
and those of the conventional treatment were $360. With inclusion of the value of the lost working days, the Closure
treatment was cost-saving for society, and when 40% of the patients are retired (or 60% of the productivity loss was
included), the Closure procedure became cost-saving at a level of 43 operations per year.
Conclusion: Endovenous obliteration may offer advantages over the conventional stripping operation in terms of reduced
postoperative pain, shorter sick leaves, and faster return to normal activities, and it appears to be cost-saving for society,
especially among employed patients. Because the procedure is also associated with shorter convalescence, this new method
may potentially replace conventional varicose vein surgery. (J Vasc Surg 2002;35:958-65.)
In the Western countries, operations on varicose veins
are among the most common surgical procedures. In Fin-
land, approximately 220 varicose vein operations per
100,000 inhabitants are performed each year.1 The strip-
ping operation is a relatively inexpensive day surgery pro-
cedure that needs no special instrumentation. Varicose vein
surgery is regarded as a safe and minor procedure; indeed,
the procedure is associated with significant surgical mor-
bidity and patient dissatisfaction.2
Recurrence is common after primary greater saphenous
varicose vein surgery. Rates as high as 40% at 5 years have
been reported, and approximately 20% of varicose vein
operations are done for recurrent veins.3,4 Furthermore,
reoperations also result in marked losses of productivity. In
Finland, the average sick leave time after a stripping oper-
ation has been 4 weeks (Statistics of the Finnish National
Pension Office 1997). Therefore, the economic conse-
quences of varicose vein surgery and its numerous recur-
rences for healthcare and whole society are high.
This issue has led to the development of mini-invasive
techniques to replace the traditional procedure of stripping
of the greater saphenous vein (GSV). Endovenous obliter-
ation (Closure System, VNUS Medical Technologies, Inc,
Sunnyvale, Calif) is a new method in which a catheter is
inserted percutaneously to treat the GSV insufficiency.5,6
The operative costs of this new technique are higher be-
cause of the purchasing price of the device and the dispos-
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able catheters. On the other hand, the procedure is less
invasive and may, therefore, result in shorter convalescence
and ability to resume work sooner, thus reducing the costs
of lost productivity. The purpose of this study was to
compare endovenous saphenous vein obliteration with
conventional stripping operation in a randomized fashion
and to evaluate the outcome in terms of postoperative pain,
sick leave, health-related quality of life, and cost.
PATIENTS AND METHODS
The study protocol was approved by the Ethical Com-
mittee of the Medical Faculty of the University of Oulu,
and the study was performed according to the provisions of
the Declaration of Helsinki.
Patient selection. For patient enrollment, 121 con-
secutive patients scheduled for surgical treatment of pri-
mary varicose veins at the Department of Surgery, Oulu
University Hospital, underwent examination with color
duplex ultrasonography. Screening was done between Jan-
uary and June 2000 (Appendix A, online only). A Valsalva’s
maneuver–induced reversal of blood flow lasting for at least
2 seconds was considered a sign of clinically significant
reflux. Patients suitable for day-case surgery with symptom-
atic, previously untreated, and uncomplicated GSV tribu-
tary varicosis and isolated unilateral saphenophemoral junc-
tion (SFJ) and GSV trunk insufficiency were eligible for the
study. Patients with coagulopathy or multiple, tortuous,
and large-diameter (12 mm) GSV trunks were excluded.
The tortuosity and diameter of the vein were assessed with
ultrasonography. Veins with a curve greater than 90 de-
grees were considered to be unsuitable for endovenous
treatment because of obvious problems of passage of the
fairly rigid catheter in abrupt curves. The diameter of the
vein was measured with the patient in a semisupine posi-
tion. The clinical severity of the varicose disease was graded
according to the clinical, etiologic, anatomic, and patho-
physiologic (CEAP) scoring system and its modifications,
the venous clinical severity score, the venous segmental
disease score, and the venous disability score.7,8
The trial profile is summarized in Fig 1. Originally, 36
patients with isolated GSV reflux were enrolled. Three of
the selected patients discontinued the study because of an
unsuitable schedule. The remaining 33 patients were ran-
domized with the sealed envelope method.
After the randomization, however, another four pa-
tients withdrew because of disappointment with assign-
ment to the stripping group. Another patient withdrew
after the randomization because of pregnancy.
Procedures. All the procedures were performed with
standardized balanced general anesthesia. The endovenous
obliterations were performed by a surgeon (T.R.) in collab-
oration with a radiologist (J.P.). The investigators had
performed more than 30 VNUS Closure procedures before
the start of the study. All the stripping operations also were
performed by the same experienced general surgeon (T.R.)
with the same team and in the same operating room during
November 2000. In addition, local phlebectomy with Oe-
sch hooks (Salzmann Medico, St Gallen, Switzerland) and,
Fig 1. Trial profile. GSV, Greater saphenous vein; LSV, lesser saphenous vein.
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in case of teleangiectasis, microsclerotherapy (Glicerina,
Laboratorio Terapeutico MR srl, Florence, Italy) were per-
formed in all 28 cases.
The endovenous obliteration procedure was performed
with the VNUS Closure system, for which the technical
details have been described previously.6,7 The catheter with
sheathed electrodes was inserted percutaneously with ultra-
sound scan guidance into the GSV at the ankle level
through a vascular sheath of 5F or 8F. Subsequently, the
catheter was passed up to the SFJ, and its correct position
was controlled with intraoperative ultrasound scanning.
Subcutaneous saline solution was infiltrated between the
proximal GSV and the skin. The lower limb was elevated,
and an elastic compression wrap was applied from the toes
to the groin for exsanguination of the entire GSV. Supple-
mental manual compression was used at the groin region.
The electrodes of the catheter were unsheathed, and the
wall contact of the electrodes was tested with measurement
of the impedance of the catheter. Heparinized saline solu-
tion was administered through the central lumen to rinse
the electrodes and to avoid thrombus formation. No ordi-
nary thrombosis prophylaxis was used. After the activation
of the treatment circuit, the wall temperature was allowed
to equilibrate at 85° C for 15 seconds. The catheter then
was slowly (ca 3 cm/min) withdrawn, with the temperature
within 3° C of the set temperature. The entire length of
the femoral segment of the GSV thus was treated. To avoid
damage to the saphenous nerve, the treatment was limited
to the area above the medial condyle of the tibia. Immedi-
ately after the treatment, the treated segment was evaluated
with color Doppler ultrasound scan to ensure proper oc-
clusion of the vein. This evaluation also allowed the option
of retreatment of the unoccluded segment immediately.
The length of the treated GSV segment and the pullout
time were measured.
At the beginning of the stripping operation, the groin
was dissected to fully expose the SFJ. The side branches of
the GSV at the SFJ were divided and ligated. After local
phlebectomy, the GSV was stripped from just below the
knee to the groin with the conventional flexible and dispos-
able Venostrip (Aesculap AG & CO, KG, Tuttlingen, Ger-
many) with a 9-mm olive. The calf and groin incisions were
sutured with 5/0 nonabsorbable interrupted sutures.
Postoperative care and follow-up examination.
Postoperative compression of the treated leg was standard-
ized. Knee and groin length antiembolism stockings were
applied immediately after the treatment and kept for 7 days.
No limitations were placed on mobilization, and the pa-
tients were encouraged to walk as soon as possible.
The patients recorded postoperative pain at rest, on
standing, and on walking with a visual analogue scale
(range, 0 to 10) on a daily basis during the 1st week and on
the 14th postoperative day. The short-term RAND-36
generic health-related quality of life questionnaire (validat-
ed for Finland) was used to measure health status before the
procedure and 1 and 4 weeks after surgery. The patients
also were asked to record the need and use of oral ibuprofen
(the number of 600-mg tablets) or other analgesics. A sick
leave was routinely prescribed for 5 days and continued for
as much as 2 weeks if necessary. If disability lasted for more
than 2 weeks, the patient was scheduled for a control visit at
the outpatient clinic.
The patients underwent reexamination after 7 to 8
weeks with color duplex ultrasonography. The postopera-
tive CEAP scores were recorded. The patients also were
asked whether they were satisfied with the treatment and
how long a sick leave was necessary in their own opinion.
The outcome measures were the duration of sick leave,
pain, health-related quality of life, and satisfaction with the
treatment.
Calculation of costs. For a cost analysis, the costs
were divided into direct medical costs and indirect costs.
The direct medical costs consisted of fixed and variable costs
as seen in Table I. Indirect costs consisted of the value of lost
productivity.
Costs that could be assumed to be the same in both
procedures (eg, administrative work, energy, overhead)
were excluded. Operating times (“skin-to-skin”) and oper-
ating room and recovery room times were measured in
minutes and valued on the basis of the average salary
brackets and figures drawn from the hospital accounting
system. Anesthesia and recovery room costs were estimated
to be US $72 in both methods. Two specialists were
involved in the VNUS operation compared with one in the
conventional alternative. The hourly salary of a specialist
was $32. Investment costs included only the cost of the
generator and were allocated to 5 years with a 5% social
discount rate. The basic instrumentation was the same in
both operations. The VNUS Closure specific costs further
included the price of the catheter and the rent of the
ultrasound scan equipment. The other costs of day surgery
were assumed to be the same. The postoperative costs
included the additional follow-up visits and telephone con-
sultations needed to lengthen sick leaves. The patient med-
ical costs were assumed to be the same, with the exception
of the analgesics used during the first 2 weeks and the travel
costs as a result of the follow-up visits. The units and the
unit values of the cost factors and the sum totals are shown
in Table I. The indirect costs were calculated as costs caused
by lost productivity because of sick leave. The value of the
lost workdays was assessed on the basis of the average wage
level in Finland in the year 20009 plus 50% nonwage costs
for social security and other worker-based costs. A 5-day
work week was used in the calculation of indirect costs.
Statistical analysis. The serial measurements were
summarized with calculation of the average score over the
study period for each patient. The change from the baseline
health-related quality of life scores to those recorded at 1
week and 4 weeks after surgery was determined, and the
other intergroup comparisons were made with Student t
test (TT) or with the Mann-Whitney U test as appropriate.
The categoric values were analyzed with the 2 or Fisher
exact test. Kendall rank correlation coefficient () and co-
efficient of determination (2) were calculated (Appendix
B, online only).
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Sensitivity analysis was done to estimate the effects of
the changes in the main background variables. The influ-
ence of indirect costs was tested with 50% of the estimated
costs. The influence of the retired patients on the indirect
costs was tested with the assumption that 25% or 40% of the
patients were retired. The scenario with one specialist per-
forming the whole operation and no discounting of invest-
ment costs also was analyzed. Two-way sensitivity analysis
was performed, with the assumption that one specialist
performed the operation and that the indirect costs ac-
counted for 50%, 60%, or 75% of the estimated costs. The
influence of the possible higher investment costs in the
United States were tested with $18,000 as a cost for the
generator and $446 for the catheter (values from US ex-
pert).
RESULTS
Twenty-eight patients were allocated into the treat-
ment groups and completed the study. Fifteen patients
were in the endovenous obliteration group, and 13 patients
were in the stripping group (Fig 1).
The basic characteristics of the patients were similar in
both groups, with the exception of the higher mean age in
the stripping group (P  .045, with TT; Table II). One
patient retired after randomization but was not withdrawn
from the study.
The procedures were performed on a day surgery basis.
As evidence of successful standardization of general anes-
thesia, no significant differences were seen in the bispectral
index, sevoflurane minimum alveolar concentration, imme-
diate recovery from anesthesia, or home readiness. Two
patients (one from each group) had to stay in the hospital
overnight because of social reasons.
The mean operation time (75 minutes, standard devi-
ation [SD] 16.6, versus 57 minutes, SD 11.0, P  .003)
and operating room time (115 minutes, SD 18.3, versus 99
minutes, SD 12.9, P .01) were significantly longer in the
endovenous obliteration group. These times are used in
the cost analysis presented in Table I. The differences in the
recovery room times (obliteration: 227 minutes, SD 57.6;
versus stripping: 198 minutes, SD 40.7; P  .16) were not
statistically significant.
The mean follow-up time was 50 days in both groups.
In all cases, endovenous obliteration was successfully per-
formed with no duplex scan–detectable flow in the treated
GSV segments. Consequently, the postoperative venous
segmental disease score fell from 1 to 0 in all patients of this
group. One patient in the stripping group had reflux in an
Table I. Costs of VNUS Closure and conventional surgery in treatment of primary varicose veins (US dollars*)
Conventional operation VNUS Closure operation
Units and unit price Total Units and unit price Total
Fixed costs
Generator 0 0 1/$14.54 14.540
Annual cost (5% discount rate) 0 3.360
Variable costs
Surgeon’s salary 99 min/$32 53 115 min/$32 61
Radiologist’s salary 0 0 75 min/$32 40
Operating room time 99 min/$73 121 115 min/$73 140
Anesthesia and recovery room 1/$72 72 1/$72 72
Basic instrumentation 1/$50 50 1/$50 50
Closure catheter 0 0 1/$446 446
US equipment rent 0 0 1/$31 31
Postoperative costs
Additional follow-up 6/13 patients/$62 29 1/15 patients/$62 4
Sick leave by telephone 13/13 patients/$28 28 33%/$28 9
Travel to follow-up visit 6/13 patients/$8 4 1/15 patients/$8 1
Analgesic medication 1.3 tablets 14 days/$0.3 6 0.4 tablets 14 days/$0.3 2
Total variable costs 360 794
Indirect costs
LWD 11.6 LWD/$135 1.566 4.5 LWD/$135 607
LWD, Lost working days.
Table II. Patient characteristics
EOG
(n  15)
SOG
(n  13)
Mean age (y) 33 (SD, 6.7) 38 (SD, 6.8)
Female/male gender 14/1 12/1
Mean BMI 23.3 (SD, 5.3) 24.0 (SD, 1.7)
Mean maximum diameter of
GSV (mm)
6.4 (SD, 1.7) 6.1 (SD, 1.3)
Occupation (No. of patients)
Office work 7 6
Light physical work 7 6
Heavy physical work 1 –
Retired – 1
CEAP classification (median
 range)
VCSS 5 (4 – 9) 4 (4 – 6)
VSDS 1 (constant) 1 (constant)
VDS 1 (1 – 2) 1 (constant)
EOG, endovenous obliteration group; SOG, stripping operation group;
GSV, greater saphenous vein; VCSS, venous clinical severity score; VSDS,
venous segmental disease score; VSD, venous disability score.6
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accessory branch of GSV, which resulted in a score of 1 after
surgery. The average decrease of the venous clinical severity
score was 5.1 (SD, 1.5) in the endovenous obliteration
group and 4.4 (SD, 1.1) in the stripping group (P  .19,
with TT). The postoperative venous disability score was 0
in all but two patients (one from each group), who occa-
sionally needed compression stockings while working.
Intraoperative complications consisted of a painful
groin hematoma (stripping group) and three small second-
degree thermal skin injuries (endovenous obliteration
group). The burns did not need specific treatment and
healed completely. These three patients, however, had ten-
derness and induration over the course of the treated GSV
segment. In one of these cases, thermal burn scar was
noticed at the time of follow-up visit and was considered as
a late complication (Table III). Saphenous nerve paresthesis,
defined as numbness or dysesthesia, which was limited to
the thigh, developed after two endovenous procedures and
three stripping operations. On the whole, minor postoper-
ative complications were common in both groups, with
seven in the endovenous obliteration group and seven in
the stripping operation group (Table III). None of the
complications caused any need for treatment or resulted in
increased costs.
The average visual analogue scale pain scores at rest, on
standing, and on walking were significantly lower in the
endovenous obliteration group than in the stripping group
(rest: 0.7, SD 0.5, versus 1.7, SD 1.3, P  .017; standing:
1.3, SD 0.7, versus 2.6, SD 1.9, P .026; walking: 1.8, SD
0.8, versus 3.0, SD 1.8, P  .036; with TT). The differ-
ences were especially clear from the 5th to the 14th post-
operative day (Fig 2). Patients in the endovenous oblitera-
tion group also needed less analgesics than those in the
stripping group (average daily number of 600-mg ibupro-
fen tablets, 0.4, SD 0.49, versus 1.3, SD 1.09, P  .004,
with Mann-Whitney U test).
The sick leaves were significantly shorter in the en-
dovenous obliteration group (6.5, SD 3.3, versus 15.6, SD
6.0; 95% CI, 5.4 to 12.9; P  .001, with TT). An even
more distinct difference was seen in the patients’ own
assessment of the length of the required sick leave (6.1, SD
4.4, versus 19.2, SD 10.0; 95% CI, 7.2 to 18.9; P  .001,
with TT). A positive correlation between age and sick leave
(  0.37; P  .012) was observed (Appendix B, online
only).
The changes in the health-related quality of life param-
eters are shown in Table IV. Physical function was restored
faster in the endovenous obliteration group. All patients
were satisfied with the treatment, but one patient in the
endovenous obliteration group and four in the stripping
group were dissatisfied with the cosmetic outcome.
The cost analysis results showed that the annual cost of
the VNUS Closure generator was about $3400, which
would have meant $120 per operation if all of our trial
operations had been performed with the Closure procedure
(Table I). The operative costs of the endovenous oblitera-
tion were significantly higher, mainly because of the cost of
the catheter. However, the combined cost effect of the
additional specialist and the rent of the ultrasound scan
Table III. Postoperative complications after closure
procedure and stripping operation for primary varicose
veins
Closure
procedure
(n  15)
Stripping
operation
(n  13)
Saphenous nerve paresthesia 2 (13%) 3 (23%)
Clinical thrombophlebitis 3 (20%) –
Local hematoma 1 (7%) 4 (31%)
Thermal skin injury 1 (7%) –
Total 7 (47%) 7 (54%)
Fig 2. Median pain scores with 25th and 75th percentiles at rest
and on standing and walking. (Daily P values were calculated with
Mann-Whitney U test). EOG, Endovenous obliteration group;
SOG, stripping operation group; VAS, visual analogue scale.
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equipment was much smaller. The effects of the longer
operation times in the endovenous obliteration were
quite modest. Although all of the postoperative medical
costs were somewhat higher in the conventional surgery
group, they did not have any major effect on the total
variable costs of the alternatives. Although the variable
costs of the conventional operations were about half of
the endovenous obliteration costs, the total societal costs
of the conventional operation were at least $300 higher
than those of the Closure procedure (Fig 3). Thus, the
indirect costs had a significant impact on the total soci-
etal costs.
The sensitivity analysis results showed that the use of
one specialist in the operation did not change the cost
curves significantly (Fig 3). The effect of use of only half of
the indirect costs was great, especially in the conventional
group. If half of the indirect costs were included in the cost
analysis, the endovenous obliteration became cost-saving
after about 150 operations per year, with one specialist for
the operation. The influence of the retired patients on the
indirect costs was also great. If 25% of the patients were
retired, the Closure operation was cost saving (at least 20
patients). The break-even point for 40% of retired patients
(60% of indirect costs) was 43 patients. High investment
costs for the generator and the catheter would have raised
the Closure cost curves about $370. In the basic alterna-
tives, the Closure operation would then have been cost
saving at the level of 40 patients per year.
DISCUSSION
This study is the first randomized trial comparing en-
dovenous obliteration with traditional stripping operation
in the treatment of primary varicose veins. According to our
findings, endovenous obliteration resulted in less postop-
erative pain, shorter sick leaves, and faster recovery of
physical function than traditional surgery. Closure proce-
dure has higher operating costs but involves potential eco-
nomic advantages for employed patients because of their
ability to resume work sooner.
The idea of use of endovenous electrosurgical devices
for venous wall collagen denaturation is not new. During
the past few decades, sporadic reports concerning proce-
Table IV. Quality of life indexes (RAND-36), at baseline and 1 week and 4 weeks postoperatively after surgery
Dimension
Median difference from baseline score (baseline-postoperative value)
Median (25th-75th percentile)
Baseline
Median (25th-75th percentile)
1 week postoperative
Median (25th-75th percentile)
4 weeks postoperative
EOG SOG EOG SOG P* EOG SOG P*
Physical functioning 95 (88-100) 95 (85-100) 30 (21-48) 50 (35-65) .07 0 (5-4) 5 (0-10) .11
Role functioning/physical 100 (100-100) 100 (50-100) 75 (38-100) 75 (25-100) .8 0 (0-0) 0 (25-0) .9
Bodily pain 68 (68-90) 68 (68-90) 23 (5-24) 38 (20-45) .05 23 (28-0) 10 (33-0) .6
General health perception 75 (68-88) 75 (70-90) 0 (0-8) 0 (5-10) .7 5 (8-0) 5 (5-10) .7
Energy 70 (60-83) 70 (50-75) 10 (3-20) 0 (10-15) .5 10 (10-0) 10 (25-10) .13
Social functioning 100 (88-100) 100 (78-100) 23 (0-31) 25 (13-50) .4 0 (13-0) 0 (0-0) .3
Role functioning/emotional 100 (100-100) 100 (67-100) 0 (0-0) 0 (0-0) .9 0 (0-0) 0 (0-0) .5
Emotional well-being 76 (74-86) 80 (64-84) 4 (6-4) 4 (8-4) .7 4 (8-0) 8 (8-0) .4
*Comparison between endovenous obliteration and stripping operation groups (with Mann-Whitney U test).
EOG, Endovenous obliteration group; SOG, stripping operation group.
Fig 3. Sensitivity analysis of costs of VNUS Closure and conventional surgery in treatment of primary varicose veins
in different numbers of patients per year (US dollars).
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dures to eliminate truncal or tributary varicosities with
monopolar electrosurgical desiccation have been pub-
lished.10-14 The system used in this study (Closure System)
was on the basis of an advanced method, including precise
heating, feedback controlled with the venous wall temper-
ature, and impedance.5
The procedures were equally efficient in elimination of
reflux in the treated GSV segments. The postoperative
changes in CEAP classification did not differ, either. The
overall complication rates were similar in the two groups,
although a difference was found in the distribution of the
types of complication.
The endovenous obliteration procedure duration was
18 minutes longer than the conventional procedure. This
trial was performed partly during the learning curve of
endovenous obliteration because our surgical team per-
formed only 30 procedures before the initiation of this
study and the experiences from other centers with the
procedure were also dated back only about 2 years. This
short experience time could have influenced the operating
times and some of the short-term results (ie, complications).
In this study, the minimally invasive nature of the
endovenous obliteration technique resulted in reduced
postoperative pain and use of analgesics. Almost half of
the patients in the stripping group had pain and tension in
the thigh 2 weeks after the operation, which seemed to be
the main cause of prolonged sick leaves among these pa-
tients. In addition, the pain disturbed knee motion and
walking, thus delaying the recovery of normal physical
function. However, the lack of blinding in this study may
likely have had some influence on patients’ subjective eval-
uation of postoperative pain. The patients were slightly
older in the stripping group, and a positive correlation
between age and sick leave emerged. According to the
coefficient of determination, however, age explained only
14% of the length of the sick leave. Thus, we believe that the
results were not distorted on the account of this random-
ization-based difference.
The patient’s subjective opinions about the appropriate
duration of the sick leave were consistent with the sick
leaves actually prescribed. Furthermore, the changes in the
health-related quality of life parameters, physical function-
ing, and bodily pain at 1 week after the procedures support
the reliability of the finding concerning significantly shorter
sick leaves after endovenous obliteration (Appendixes C
and D, online only).
Our sample included employed patients, which in-
creased the influence of the indirect costs on the cost
analysis. The sensitivity analysis showed that even if 25% to
40% of the patients were retired, the Closure operation
could be economically cost-minimizing in the perspective
of the society. The possible country-specific differences in
the investment costs and the cost of the catheter have
relatively small effects on the average cost of the Closure
procedure. In addition, because the two alternatives used
about the same amount of other healthcare resources, the
differences in the values of the other cost factors do not
have a significant influence on the results of the cost anal-
ysis.
Because the differences in the postoperative pain and
other complications lasted for only a few weeks, cost com-
parison and cost minimization analyses are appropriate
methods of economic evaluation.15 In this case, the
method is closer to cost comparison analysis because of the
minor differences in the effectiveness of the treatments, at
least according to the short-term results.
Varicose vein recurrence, defined as the proportion of
patients seeking further treatment after apparently ade-
quate surgery, is seen in at least 20% to 30% of the cases and
tends to increase over time.16 This causes an extra financial
burden on general surgical units and induces costs for
society. Endovenous obliteration omits high ligation and
leaves accessory tributaries of the SFJ, which can be re-
garded as a risk for recurrence. However, with Closure
treatment without SFJ ligation, the normal venous drain-
age of the lower abdominal and pudendal tissues is pre-
served. This may reduce the stimulus to neovasculariza-
tion.17 Because angiogenesis is regarded as an important
cause of recurrent reflux,18-21 endovenous obliteration may
actually reduce the risk of recurrent varicosities. Long-term
follow-up periods are, however, needed to better evaluate
whether the recurrence rate could be reduced with the
Closure procedure.
In conclusion, our results indicated that endovenous
obliteration may offer an advantage over conventional
stripping operation in terms of reduced postoperative pain,
shorter sick leaves, and faster return to normal activities. We
also conclude that endovenous obliteration was more ex-
pensive for the hospital. In this study, the total costs, which
also included the costs incurred by society because of sick
leaves, were no higher than the total costs of the conven-
tional stripping operation. More information is needed on
the long-term results and recurrence rates, and larger stud-
ies are needed to determine the precise role of this proce-
dure in the treatment of primary varicose veins. A thorough
assessment of varicose vein surgery would necessitate a
long-term cost-effectiveness or cost-benefit analysis of
these alternatives.
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